IN2015DN03169A - - Google Patents

Info

Publication number
IN2015DN03169A
IN2015DN03169A IN3169DEN2015A IN2015DN03169A IN 2015DN03169 A IN2015DN03169 A IN 2015DN03169A IN 3169DEN2015 A IN3169DEN2015 A IN 3169DEN2015A IN 2015DN03169 A IN2015DN03169 A IN 2015DN03169A
Authority
IN
India
Prior art keywords
extract
formulations
vaccinia virus
greater uniformity
rabbit skin
Prior art date
Application number
Inventor
Yoshitaka Nakazawa
Yoji Shibayama
Ko Nakamura
Original Assignee
Nippon Zoki Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2012225133A external-priority patent/JP5275502B1/en
Priority claimed from JP2013092006A external-priority patent/JP5438234B1/en
Application filed by Nippon Zoki Pharmaceutical Co filed Critical Nippon Zoki Pharmaceutical Co
Publication of IN2015DN03169A publication Critical patent/IN2015DN03169A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)

Abstract

The objective of the present invention is to provide an extract from inflamed rabbit skin inoculated with vaccinia virus and formulations etc. including the extract which have greater uniformity in quality. By using the amount of N acetyl neuraminic acid contained in the extract from inflamed rabbit skin inoculated with vaccinia virus and the formulations including the extract as an index greater uniformity of the extract and the formulations can be ensured for each production lot. The extract from inflamed rabbit skin inoculated with vaccinia virus and the formulations including the extract which are produced in this manner so as to have greater uniformity are extremely useful with effectiveness and safety more rigorously secured.
IN3169DEN2015 2012-10-10 2013-10-09 IN2015DN03169A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012225133A JP5275502B1 (en) 2012-10-10 2012-10-10 Extracts and formulations
JP2013092006A JP5438234B1 (en) 2013-04-25 2013-04-25 Extract and formulation containing the extract
PCT/JP2013/077534 WO2014057995A1 (en) 2012-10-10 2013-10-09 Extract and formulation including extract

Publications (1)

Publication Number Publication Date
IN2015DN03169A true IN2015DN03169A (en) 2015-10-02

Family

ID=49359802

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3169DEN2015 IN2015DN03169A (en) 2012-10-10 2013-10-09

Country Status (10)

Country Link
US (2) US20150265655A1 (en)
EP (1) EP2910249B1 (en)
KR (1) KR102131025B1 (en)
CN (4) CN103357006B (en)
AU (1) AU2013327849B2 (en)
CA (1) CA2887117C (en)
HK (1) HK1211496A1 (en)
IN (1) IN2015DN03169A (en)
TW (1) TWI594757B (en)
WO (1) WO2014057995A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014178394A1 (en) * 2013-04-30 2014-11-06 日本臓器製薬株式会社 Extract, and preparation containing said extract
TWI705816B (en) * 2016-01-29 2020-10-01 國立大學法人千葉大學 Use of extract from inflamed tissue inoculated with vaccinia virus for manufacturing prevention or therapeutic agent or repair accelerator of muscle damage
CN109504649B (en) * 2017-09-15 2022-06-14 天津小西生物医药科技有限公司 Method for promoting cell proliferation by using rabbit skin extract
CN109512838B (en) * 2017-09-15 2022-05-10 天津小西生物医药科技有限公司 Rabbit skin extract and preparation method and application thereof
JP2019142802A (en) * 2018-02-20 2019-08-29 学校法人東海大学 Agent for promoting expression of n-acetylgalactosaminyltransferase containing extract from inflamed tissues inoculated with vaccinia virus

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6176193A (en) 1984-09-21 1986-04-18 工業技術院長 Hem continuously folding apparatus of processed cloth
JPS61142268A (en) 1984-12-17 1986-06-30 松下電器産業株式会社 Electric unocking apparatus
JP2594222B2 (en) 1993-09-28 1997-03-26 日本臓器製薬株式会社 New physiologically active substance-KF
CN1055249C (en) 1998-07-15 2000-08-09 沈继平 Analgesia medicine and its mfg. method
KR101097138B1 (en) * 2002-10-31 2011-12-22 니폰 조키 세야쿠 가부시키가이샤 Remedy for fibromyalgia
CN1207005C (en) 2002-10-31 2005-06-22 威世药业（如皋）有限公司 Rabbit skin containing bioactive substance and its use
JP3818657B2 (en) 2004-12-01 2006-09-06 日本臓器製薬株式会社 Dried product and production method thereof
CN1613305B (en) 2004-12-06 2011-01-12 威世药业（如皋）有限公司 Active agent containing biological active substances from cony fur
CN100542543C (en) 2005-06-17 2009-09-23 日本脏器制药株式会社 Dry thing and autofrettage thereof
JP4005115B1 (en) * 2007-02-08 2007-11-07 日本臓器製薬株式会社 Pain disease treatment
TWI483729B (en) * 2010-03-11 2015-05-11 Nippon Zoki Pharmaceutical Co Improving or therapeutic agent for chronic prostatitis, interstitial cystitis and/or urinary disturbance
WO2011162317A1 (en) * 2010-06-25 2011-12-29 日本臓器製薬株式会社 Method for determination or evaluation of substance of interest
WO2014178394A1 (en) 2013-04-30 2014-11-06 日本臓器製薬株式会社 Extract, and preparation containing said extract

Also Published As

Publication number Publication date
CA2887117C (en) 2021-03-09
EP2910249B1 (en) 2019-12-04
US20150265655A1 (en) 2015-09-24
US11529374B2 (en) 2022-12-20
WO2014057995A1 (en) 2014-04-17
CA2887117A1 (en) 2014-04-17
EP2910249A1 (en) 2015-08-26
CN103357006A (en) 2013-10-23
CN106109498A (en) 2016-11-16
US20190151370A1 (en) 2019-05-23
TWI594757B (en) 2017-08-11
AU2013327849A1 (en) 2015-04-30
KR20150064036A (en) 2015-06-10
CN104703613A (en) 2015-06-10
CN104703613B (en) 2016-08-17
CN103357006B (en) 2014-10-15
HK1211496A1 (en) 2016-05-27
AU2013327849B2 (en) 2017-12-07
KR102131025B1 (en) 2020-07-07
TW201438724A (en) 2014-10-16
EP2910249A4 (en) 2016-07-27
CN106074607A (en) 2016-11-09
CN106109498B (en) 2020-06-02

Similar Documents

Publication Publication Date Title
MX369388B (en) Heterocyclic modulators of lipid synthesis.
PH12015502839B1 (en) Antiviral compounds
EA201590868A1 (en) ANTI-VIRUS COMPOUNDS
MX2019009283A (en) PCSK9 iRNA COMPOSITIONS AND METHODS OF USE THEREOF.
EA201790963A1 (en) ANTI-VIRUS COMPOUNDS
CO6511271A2 (en) IMIDAZOPIRIDINIL-AMINOPIRIDINE SUBSTITUTED COMPOUNDS
IN2015DN03029A (en)
ECSP14013327A (en) COMPOUNDS WITH NEMATICIATED ACTIVITY
AU347707S (en) Diaphragm pump
IN2014MN01331A (en)
EA201491537A1 (en) Increase in Drought Resistance in Plants: UPL3
IN2015DN03169A (en)
IN2012MU03723A (en)
IN2014DN06104A (en)
MX2019011805A (en) Melon plants with melon yellowing associated virus (myav) resistance.
BR112012016894A2 (en) lactobacilli with antioxidant action.
BR112015002464B8 (en) process for the preparation of carbamat-benzoxazinone, carbamat-benzoxazinone and use of carbamat-benzoxazinone
CO7160080A2 (en) Lipid compositions of racecadot
BR112015008824A2 (en) improved microalgae strains and process
BR112012030742A2 (en) quaternary dialcanolamine esters
FI20115328A (en) New cutinases, their production and uses
BR112012030412A2 (en) quaternary dialcanolamine esters
IN2014MN01469A (en)
EA201590564A1 (en) STABLE COMPOSITIONS
AU338093S (en) Street light